My Stocks Explore Events Please signup to use this feature
Please signup to use this feature
Please signup to use this feature
Please signup to use this feature
Live today
{{event.ticker}} @{{event.event_utc_datetime | date:'h:mm a'}}
{{market.market_short_name}} {{market.last_price | number : 2}}

Want to join the conversation?

$MATX {{ '2016-09-15T12:50:52+0000' | timeago}} • Announcement

$MATX issued $200MM in privately placed 15-year final maturity senior unsecured notes pursuant to a previously announced commitment letter on July 18, 2016. The senior notes will have a weighted average life of approx. 8.5 years and will bear interest at a rate of 3.14%, payable semi-annually.

User RC xNair {{ '2016-10-25T17:04:47+0000' | timeago}}

Looking ahead to $AAPL earnings release later in the afternoon today? Gene Munster, analyst from Piper Jaffrey and the most respected authority for Apple, had this to say - "The second and slightly larger group of investors believe the tail of the iPhone 7 is irrelevant, and is betting that the iPhone 10th Anniversary will yield a jump in growth from flat to up ~15%."

User Carlton Davis {{ '2016-10-24T19:31:20+0000' | timeago}}

$COL agreed to buy $BEAV for $6.4 billion in cash and stock. Also Rockwell Collins reported higher 4Q16 earnings on growth in Government Systems and higher revenue in Information Management Services.

User Charles Elliston {{ '2016-10-24T19:15:21+0000' | timeago}}

Wow! What a buzz the $T-$TWX deal is making! Almost everyone from politicians to competitors have come out against this deal. Even Wall Street doesn’t seem to be too thrilled. Both stocks were down today.

User Vishnu Beri {{ '2016-10-24T17:33:28+0000' | timeago}}

Visa ($V) set to release it earning after market close today. With new CEO resigning so close to the earnings, should we expect to see any surprises? Visa has been making strong moves with Visa Europe acquisition, partnership with PayPal and a 15% increase if quarterly dividends.

User Vishnu Beri {{ '2016-10-24T17:05:39+0000' | timeago}}

Kimberly Clark Corp ($KMB) has been in decline for most of the year, the stock has also not been getting any analyst love. Will today’s earnings break the trend? Revenue has been up and down in the last four quarters, let us see what this quarter brings.

$MM {{ '2016-10-25T17:42:15+0000' | timeago}} • Webcast

$MM said it repurchased $2.8Bil of its stock YTD and expects to repurchase $3.5-4.5Bil for FY16. The company also said the repurchase is dependent on capital demands such as M&A and relative value and price of the stock.

$GLW {{ '2016-10-25T17:36:29+0000' | timeago}} • Webcast

$GLW said that on a consolidated basis, the company expects 4Q16 GM to be consistent with 3Q16 at 43%. The company added that this guidance reflects the higher sales it expects in Optical Communications segment and YoverY cost reductions in the Display segment.

$LLY {{ '2016-10-25T17:36:10+0000' | timeago}} • Webcast

$LLY said LARTRUVO is the first FDA approved front-line therapy for soft tissue sarcoma in four decades. It also marks the third product from the company's ImClone acquisition to receive regulatory approval. This is an accelerated approval based on data from the company's Phase II trial.

$GLW {{ '2016-10-25T17:33:43+0000' | timeago}} • Webcast

In Specialty Materials, $GLW expects high single digit YoverY sales growth in 4Q16, driven by volume growth in Gorilla Glass. In Life Sciences, 4Q16 sales are expected to up low single digits YoverY.

$MAS {{ '2016-10-25T17:31:18+0000' | timeago}} • Webcast

$MAS spent around $65-70MM on share buybacks and has got a real cash hoard close to $1Bil available on balance sheet. $MAS said it is going to continue its disciplined capital allocation program and reinvest in business. $MAS thinks it is a balancing act to buyback more stock on a regular basis when the extent of valuations are too frothy.